Attached files
file | filename |
---|---|
10-K - ORAMED PHARMACEUTICALS INC. | v204045_10k.htm |
EX-31.2 - ORAMED PHARMACEUTICALS INC. | v204045_ex31-2.htm |
EX-31.1 - ORAMED PHARMACEUTICALS INC. | v204045_ex31-1.htm |
EX-23.2 - ORAMED PHARMACEUTICALS INC. | v204045_ex23-2.htm |
EX-23.1 - ORAMED PHARMACEUTICALS INC. | v204045_ex23-1.htm |
EXHIBIT
32.1
CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER
AND
PRINCIPAL FINANCIAL OFFICER
PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS
(A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED
STATES CODE)
Pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
section 1350, chapter 63 of title 18, United States Code), each of the
undersigned officers Oramed Pharmaceuticals Inc., a Nevada corporation (the
“Company”), does hereby certify, to such officer’s knowledge, that the Annual
Report for the fiscal year ended August 31, 2010 (the “Form 10-K”) of the
Company fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and the information contained in the Form 10-K
fairly presents, in all material respects, the financial condition and results
of operations of the Company.
Dated: November 26, 2010
|
/s/ Nadav Kidron
|
Nadav Kidron, President and Chief Executive Officer
|
|
Dated: November 26, 2010
|
/s/ Yifat Zommer
|
Yifat Zommer, Chief Financial Officer
|
A signed
original of this written statement required by Section 906 has been provided by
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.